Interventions for managing medication-related osteonecrosis of the jaw
Interventions for managing medication-related osteonecrosis of the jaw
Cochrane Review
5 SoF Entries
Summary of Findings
Key results and quality assessments using GRADE methodology
| Outcome | Effect | Participants | Studies | Certainty |
|---|---|---|---|---|
|
Patient-reported pain intensity or pain relief (VAS 1-100mm) - 24 hours
placebo |
-20.27 | - | - | Not assessed |
|
Adverse effects
placebo |
nan | - | - | Not assessed |
|
Patient-reported pain intensity or pain relief (VAS upon chewing 1-100mm) - 24 hours
placebo or no chewing gum |
-15.38 | - | - | Not assessed |
|
Adverse effects for BWM
no special instructions |
nan | - | - | Not assessed |
|
Adverse effects for CBT
no special instructions |
nan | - | - | Not assessed |
GRADE Certainty of Evidence:
High
Very confident in the effect estimate
Moderate
Moderately confident in the effect estimate
Low
Limited confidence in the effect estimate
Very Low
Very little confidence in the effect estimate
Review Information
| Review ID: | CD010263 |
| Outcomes: | 5 assessed |
Related Content
Evidence Quality Distribution:
Not assessed:
5